Results
1
-
10
of
213
<
1
2
3
...
21
22
>
Sasaki YF; Nishidate E; Su YQ; Matsusaka N; Tsuda S; Susa N; Furukawa Y; Ueno S.
Organ-specific genotoxicity of the potent rodent bladder carcinogens o-anisidine and p-cresidine.
,
Mutation research
Ashby J; Lefevre PA; Tinwell H; Brunborg G; Schmezer P; Pool-Zobel B; Shanu-Wilson R; Holme JA; Soderlund EJ; Gulati D.
The non-genotoxicity to rodents of the potent rodent bladder carcinogens o-anisidine and p-cresidine.
,
Mutation research
Bolcsfoldi G; Hellm?r L.
Comments on the paper 'The non-genotoxicity to rodents of the potent bladder carcinogens o-anisidine and p-cresidine'.
,
Mutation research
p-Cresidine.
,
Report on carcinogens : carcinogen profiles
p-Cresidine.
,
Report on carcinogens : carcinogen profiles
p-Cresidine.
,
Report on carcinogens : carcinogen profiles
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW.
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
,
Carcinogenesis
Hulla JE; French JE; Dunnick JK.
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
,
Carcinogenesis
Delker DA; Yano BL; Gollapudi BB.
Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice.
,
Toxicological sciences : an official journal of the Society of Toxicology
Dunn SE; Kari FW; French J; Leininger JR; Travlos G; Wilson R; Barrett JC.
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
,
Cancer research
<
1
2
3
...
21
22
>